PE and PH

Dr. Mulinzi Solomon; Dr. Katuramu Richard

Pulmonary embolism (PE) is a common, potentially fatal condition whose clinical presentation is variable and often nonspecific. The document outlines epidemiologic trends, risk groups, and the temporal classification of PE (acute, sub‑acute, chronic). It details anticoagulant options, including the role of direct oral anticoagulants (DOACs) and considerations in chronic kidney disease. The material also addresses pulmonary hypertension, especially chronic thrombo‑embolic pulmonary hypertension, and its therapeutic strategies such as lifelong anticoagulation, endarterectomy, and balloon pulmonary angioplasty.